ERK Inhibitor JSI-1187 in Advanced Solid Tumors

Conditions: Solid Tumor; NSCLC; Melanoma Interventions: Drug: JSI-1187 Sponsors: JS InnoPharm, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials